Sélectionner une page

DiogenX

Description: DiogenX develops pancreatic beta-cell modulators for diabetes treatment, aiming to create the first beta-cell regeneration drug.
Country: France
Based in: Marseille
Founded: 2019
Funding Stage: Pre-Seed
Tags: ['Biotechnology', 'Life Science', 'healthcare']

Categories

Details about how we process your information are available in our Privacy Policy.